UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature reviews. Drug discovery, ISSN 1474-1776, 2014, Volume 13, Issue 6, pp. 433 - 444
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Intestines - drug effects | Intestinal Mucosa - metabolism | Drugs, Investigational - pharmacology | Humans | Drugs, Investigational - therapeutic use | Orphan Nuclear Receptors - metabolism | Brain - metabolism | Drugs, Investigational - chemistry | Protein Isoforms - metabolism | Liver - drug effects | Alzheimer Disease - prevention & control | Liver X Receptors | Drug Design | Neurons - metabolism | Hypolipidemic Agents - chemistry | Drug Evaluation, Preclinical | Neurons - drug effects | Hypolipidemic Agents - adverse effects | Nerve Tissue Proteins - antagonists & inhibitors | Molecular Targeted Therapy - adverse effects | Atherosclerosis - drug therapy | Liver - metabolism | Alzheimer Disease - drug therapy | Nootropic Agents - therapeutic use | Clinical Trials as Topic | Hypolipidemic Agents - pharmacology | Nootropic Agents - adverse effects | Nootropic Agents - chemistry | Drug Discovery | Atherosclerosis - metabolism | Brain - drug effects | Nerve Tissue Proteins - metabolism | Orphan Nuclear Receptors - antagonists & inhibitors | Animals | Signal Transduction - drug effects | Alzheimer Disease - metabolism | Lipid Metabolism - drug effects | Hypolipidemic Agents - therapeutic use | Atherosclerosis - prevention & control | Nootropic Agents - pharmacology | Protein Isoforms - antagonists & inhibitors | Care and treatment | Research | Drug discovery | Patient outcomes | Risk factors | Atherosclerosis | Index Medicus
Journal Article
Human molecular genetics, ISSN 0964-6906, 2014, Volume 23, Issue 17, pp. 4491 - 4509
Biochemistry & Molecular Biology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Neurons - pathology | Humans | alpha-Synuclein - ultrastructure | Saccharomyces cerevisiae - drug effects | Protein Transport - drug effects | Brain - metabolism | Saccharomyces cerevisiae - metabolism | Cell Nucleus - metabolism | Protein Binding - drug effects | Sodium Dodecyl Sulfate - pharmacology | Cell Membrane - metabolism | Neurons - metabolism | alpha-Synuclein - genetics | Phosphorylation - drug effects | Buffers | Inclusion Bodies - metabolism | Neurons - drug effects | Protein Aggregation, Pathological - genetics | Cell Membrane - drug effects | Neuroblastoma - pathology | Protein Aggregates - drug effects | Cell Line | Parkinson Disease - pathology | Protein Structure, Secondary | Subcellular Fractions - drug effects | Cells, Cultured | Inclusion Bodies - drug effects | Mitochondria - metabolism | alpha-Synuclein - secretion | Mitochondria - drug effects | Parkinson Disease - genetics | Mutation - genetics | Subcellular Fractions - metabolism | alpha-Synuclein - chemistry | Brain - drug effects | Unilamellar Liposomes - metabolism | Nuclear Envelope - metabolism | Nuclear Envelope - drug effects | Cell Differentiation - drug effects | Brain - pathology | Cell Nucleus - drug effects | Index Medicus
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 10/2014, Volume 57, Issue 20, pp. 8576 - 8589
Drug Evaluation, Preclinical - methods | Chemistry Techniques, Synthetic | Quinones - chemistry | Antioxidants - chemistry | Rats, Wistar | Humans | Cholinesterase Inhibitors - chemistry | Models, Molecular | Crystallography, X-Ray | Acetylcholinesterase - chemistry | Antioxidants - pharmacology | Molecular Targeted Therapy | Blood-Brain Barrier - drug effects | Hep G2 Cells - drug effects | Animals | Cholinesterase Inhibitors - pharmacology | Amyloid beta-Peptides - metabolism | Drug Design | Inhibitory Concentration 50 | Oxidative Stress - drug effects | Neurons - drug effects | Acetylcholinesterase - metabolism | Tacrine - chemistry | Index Medicus
Journal Article
Pharmaceutical research, ISSN 0724-8741, 10/2013, Volume 30, Issue 10, pp. 2512 - 2522
Biochemistry, general | Biomedical Engineering | biodegradable polymers: blood–brain barrier (BBB) | pharmaceutical nanotechnology | Biomedicine | Pharmacy | Medical Law | chemotherapeutic engineering | Pharmacology/Toxicology | gastrointestinal barrier (GI barrier) | biodegradable polymers: blood-brain barrier (BBB) | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Nanoparticles - chemistry | Humans | Vitamin E - analogs & derivatives | Male | Polyethylene Glycols - chemistry | Chromatography, High Pressure Liquid | Drug Carriers - chemistry | Polystyrenes - chemistry | Tissue Distribution | Surface Properties | Madin Darby Canine Kidney Cells | Vitamin E - chemistry | Caco-2 Cells | Fluorescent Dyes - chemistry | Vitamin E - pharmacokinetics | Administration, Oral | Polyethylene Glycols - pharmacokinetics | Rats | Rats, Sprague-Dawley | Gastrointestinal Tract - metabolism | Blood-Brain Barrier - metabolism | Endocytosis - physiology | Particle Size | Animals | Dogs | Drug Carriers - pharmacokinetics | Polystyrenes - pharmacokinetics | Drug Delivery Systems - methods | Drugs | Drug delivery systems | Vehicles | Biodegradable materials | Chemotherapy | Blood-brain barrier | Nanotechnology | Index Medicus
Journal Article
Journal of controlled release, ISSN 0168-3659, 2010, Volume 143, Issue 1, pp. 136 - 142
c(RGDyK) | PEG-PLA micelle | Glioblastoma | Paclitaxel | C(RGDyK) | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Injections, Intravenous | Humans | Brain Neoplasms - pathology | Biological Availability | Polyethylene Glycols - chemistry | Paclitaxel - pharmacokinetics | Brain Neoplasms - metabolism | Integrin alphaVbeta3 - metabolism | Peptides, Cyclic - chemistry | Peptides, Cyclic - metabolism | Drug Carriers | Dose-Response Relationship, Drug | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Micelles | Drug Compounding | Inhibitory Concentration 50 | Glioblastoma - metabolism | Paclitaxel - administration & dosage | Antineoplastic Agents, Phytogenic - pharmacokinetics | Lactates - chemistry | Cell Survival - drug effects | Antineoplastic Agents, Phytogenic - chemistry | Technology, Pharmaceutical - methods | Brain Neoplasms - drug therapy | Chemistry, Pharmaceutical | Particle Size | Xenograft Model Antitumor Assays | Animals | Tumor Burden - drug effects | Mice, Nude | Glioblastoma - pathology | Cell Line, Tumor | Mice | Glioblastoma - drug therapy | Drugs | Ethylene glycol | Polyethylene | Cell research | Drug delivery systems | Peptides | Gliomas | Analysis | Lactic acid | Integrins | Vehicles | Index Medicus
Journal Article
Journal of controlled release, ISSN 0168-3659, 06/2015, Volume 207, pp. 18 - 30
Oxidative stress | Neuroinflammation | Parkinson's disease | Catalase | Exosomes | Blood–brain barrier | Blood-brain barrier | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Antioxidants - chemistry | Antioxidants - metabolism | Oxidopamine | Anti-Inflammatory Agents - metabolism | PC12 Cells | Neuroprotective Agents - metabolism | Drug Carriers | Brain - metabolism | Nanoparticles | Parkinsonian Disorders - metabolism | Parkinsonian Disorders - drug therapy | Antiparkinson Agents - chemistry | Anti-Inflammatory Agents - administration & dosage | Female | Neurons - metabolism | Neuroprotective Agents - administration & dosage | Nanomedicine | Disease Models, Animal | Neuroprotective Agents - chemistry | Mice, Inbred C57BL | Solubility | Rats | Technology, Pharmaceutical - methods | Parkinsonian Disorders - chemically induced | Administration, Intranasal | Chemistry, Pharmaceutical | Brain - drug effects | Catalase - metabolism | Catalase - administration & dosage | Animals | Anti-Inflammatory Agents - chemistry | Antioxidants - administration & dosage | RAW 264.7 Cells | Antiparkinson Agents - administration & dosage | Mice | Kinetics | Oxidative Stress - drug effects | Antiparkinson Agents - metabolism | Catalase - chemistry | Drugs | Drug delivery systems | Proteases | Analysis | Antiparkinsonian agents | Vehicles | Index Medicus | blood-brain barrier | neuroinflammation | exosomes | catalase | oxidative stress | Parkinson’s disease
Journal Article
Annual review of psychology, ISSN 0066-4308, 2013, Volume 64, Issue 1, pp. 21 - 47
cannabidiol | reward | anxiety | memory | cognition | neurogenesis | δ9-tetrahydrocannabinol (THC) | depression | cannabinoid receptors | 2-arachidonoyl glycerol (2-AG) | anandamide | Drug addiction | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopathology. Psychiatry | Addictive behaviors | Biological and medical sciences | Medical sciences | Memory - drug effects | Endocannabinoids - pharmacology | Learning - drug effects | Humans | Cannabinoids - chemistry | Depressive Disorder - drug therapy | Cognition - drug effects | Cannabinoids - pharmacology | Brain - drug effects | Dose-Response Relationship, Drug | Receptors, Cannabinoid - drug effects | Cannabis - chemistry | Animals | Neurogenesis - drug effects | Anxiety Disorders - drug therapy | Dronabinol - chemistry | Reward | Dronabinol - pharmacology | Psychological aspects | Nerves, Peripheral | Cannabinoids | Research | Drug receptors | Psychotropic drugs | Brain | Nervous system | Mental depression | Cognition & reasoning | Drug dosages | Index Medicus
Journal Article